Anna Maria D'URSI | Projects
Anna Maria D'URSI Projects
6 Funded projects
Filter
Department | Dipartimento di Farmacia/DIFARMA | |
Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
Funding | Finanziamenti da bandi nazionali Ministeriali ed altri EEPP | |
Funders | Università degli Studi di SALERNO MINISTERO DELLA SALUTE | |
Cost | 148.064,36 euro | |
Project duration | 1 January 2023 - 31 December 2030 | |
Detail |
⿢Collect, preparation and metabolomic analysis of SMNο7 mice tissue to outline the specific-organ role of SMN gene in SMA pathology⿢Collection and preparation of biofluids (serum, urine, saliva, faeces) from fibromyalgia patients before and after ketogenic or low glycaemic index diet (LOGI)⿢Use of bioinformatics and biostatistics approach for metabolomics data analysis ⿢Integration of metab
Department | Dipartimento di Farmacia/DIFARMA | |
Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
Funding | University funds | |
Funders | Università degli Studi di SALERNO | |
Cost | 3.816,90 euro | |
Project duration | 31 July 2023 - 31 July 2026 | |
Detail |
Affiliato Spoke 6 - Biodiversity and human wellbeing (CNR)
Department | Dipartimento di Farmacia/DIFARMA | |
Principal Investigator | GRIMALDI Anna Rita (Collaborazione al Coordinatore) RASTRELLI Luca (Project Coordinator) | |
Funding | Finanziamenti da bandi nazionali Ministeriali ed altri EEPP | |
Funders | Ministero dell'Università e della Ricerca - MUR | |
Cost | 1.887.898,75 euro | |
Project duration | 1 September 2022 - 31 August 2025 | |
Detail |
Active
Alzheimer's disease (AD), is the most common neurodegenerative disorder of the aging population resulting in progressive cognitive and functional decline. Accumulation of amyloid plaques around neuronal cells is considered a critical pathogenetic event and, in most cases, a hallmark of the pathology. In the attempt to identify anti-AD drug candidates, hundreds of molecules targeting Aß peptides ha
Department | Dipartimento di Farmacia/DIFARMA | |
Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
Funding | University funds | |
Funders | Università degli Studi di SALERNO | |
Cost | 12.000,75 euro | |
Project duration | 25 July 2022 - 25 July 2025 | |
Detail |
Consulenza Analitico/Scientifica per la caratterizzazione di sostanze di interesse farmaceutico di natura peptidica
Department | Dipartimento di Farmacia/DIFARMA | |
Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
Funding | Third Party Activities - Research | |
Funders | FRESENIUS KABI IPSUM SRL | |
Cost | 35.000,00 euro | |
Project duration | 5 February 2024 - 31 December 2024 | |
Detail |
Active
The dramatic outcome of the Covid19 pandemic raised the necessity to have a general treatment to limit the evolution to severe infections. The interim result of the first vaccines showing an incomplete efficacy and the new virus variants left a therapeutic space for treatments based on different strategies. Monoclonal antibodies appear to have a promising effect, but because of their high cost the
Department | Dipartimento di Farmacia/DIFARMA | |
Principal Investigator | RODRIQUEZ Manuela (Project Coordinator) | |
Funding | University funds | |
Funders | Università degli Studi di SALERNO | |
Cost | 13.342,37 euro | |
Project duration | 22 November 2021 - 22 November 2024 | |
Detail |
Data source U-GOV dal 1 Gennaio 2013